Predictors of virologic suppression <400 copies/ml 4–12 months after restarting NNRTI-based ART.^a

aThe analysis included 90 patients who restarted NNRTI-based ART without a protease inhibitor and had at least one viral load measurement in the 4–12 months after re-starting therapy. bAs noted above some patients had the viral load measured by assays with a lower limit of quantification of either 75 or 400 copies/ml. NNRTI = non-nucleoside reverse transcriptase inhibitor; ART = antiretroviral therapy; OR = Odds ratio; CI = confidence interval.